Endocannabinoid system in appetite regulation/Related Articles: Difference between revisions
Jump to navigation
Jump to search
imported>Daniel Mietchen m (Robot: encapsulating subpages template in noinclude tag) |
No edit summary |
||
| (One intermediate revision by one other user not shown) | |||
| Line 17: | Line 17: | ||
{{r|Endocannabinoid}} | {{r|Endocannabinoid}} | ||
{{Bot-created_related_article_subpage}} | |||
<!-- Remove the section above after copying links to the other sections. --> | <!-- Remove the section above after copying links to the other sections. --> | ||
==Articles related by keyphrases (Bot populated)== | |||
{{r|Drug treatments for obesity}} | |||
{{r|Endocannabinoid}} | |||
{{r|New drug application}} | |||
Latest revision as of 11:00, 12 August 2024
- See also changes related to Endocannabinoid system in appetite regulation, or pages that link to Endocannabinoid system in appetite regulation or to this page or whose text contains "Endocannabinoid system in appetite regulation".
Parent topics
Subtopics
Bot-suggested topics
Auto-populated based on Special:WhatLinksHere/Endocannabinoid system in appetite regulation. Needs checking by a human.
- Adipose tissue [r]: Connective tissue composed of adipocytes, commonly known as "fat. [e]
- Endocannabinoid [r]: Substances produced by some nerve cells (and by some cells in the periphery) with cellular effects like those produced by cannabis. [e]
- Drug treatments for obesity [r]: Treatments of obesity that are based on drugs. [e]
- Endocannabinoid [r]: Substances produced by some nerve cells (and by some cells in the periphery) with cellular effects like those produced by cannabis. [e]
- New drug application [r]: The U.S. regulatory process under which the Food and Drug Administration authorizes the marketing of new drugs, for which it has verified safety and efficacy for specific disease indication; the prescribing information must warn of potential adverse effects [e]